Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,245,503,942
+$57,757,647 QoQ
Shares Held
6,200,994
-0.3% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#13
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 3%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. AMGN ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
This page
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,245,503,942 | 6,200,994 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,187,746,295 | 6,217,838 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,023,318,473 | 6,181,658 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,733,972,253 | 6,144,480 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,714,843,317 | 6,141,769 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,933,500,167 | 6,206,067 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,676,183,394 | 6,431,029 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,790,126,260 | 5,555,775 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,828,701,734 | 5,852,782 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,710,649,378 | 6,016,634 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,847,078,594 | 6,413,022 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,875,306,493 | 6,977,625 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,492,454,405 | 6,722,162 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,680,205,288 | 6,950,177 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,866,786,287 | 7,107,776 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,614,230,724 | 7,161,627 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,773,001,791 | 7,287,307 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,845,503,254 | 7,631,723 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $1,726,899,637 | 7,676,133 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,665,611,105 | 7,832,641 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,847,382,223 | 7,579,004 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,927,728,373 | 7,747,793 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $1,821,096,303 | 7,920,565 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,068,400,080 | 8,138,181 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,881,787,780 | 7,978,410 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,618,432,511 | 7,983,192 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||